11/2023

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

11/2023

Nov 18, 2023, 23:57 | Blog
Edward Cliff: Excited to share our work on accelerated approval and NCCN guidelines, out today
Edward Cliff, Fellow at Harvard Medical School and Brigham & Women’s Hospital, made the following…
Nov 18, 2023, 23:03 | Blog
Paul Chilwesa: Building resilience in cancer healthcare systems in LMICs requires concerted efforts
Paul Chilwesa, Population Health Impact Leader at F. Hoffmann-La Roche AG, made the following post…
Nov 18, 2023, 22:51 | Blog
Danny Burke: Our Journal's latest Special Issue is now live, covering Climate change and Oncology Nursing
Danny Burke, CEO of ecancer, made the following post on LinkedIn: "Our Journal's latest Special…
Nov 18, 2023, 19:38 | Drugs
Mark Awad: Our outstanding medical student Malini Gandhi shows that cancers with wild-type RET amplification can also be successfully targeted
Dr. Mark Awad, Associate Professor of Medicine at Harvard Medical School and Clinical Director of…
Nov 18, 2023, 19:03 | Blog
Tedros Adhanom Ghebreyesus - The current situation is unbearable and unjustifiable. Ceasefire. NOW.
Dr. Tedros Adhanom Ghebreyesus, the Director-General of WHO, shared on X (Twitter): "Today WHO led…
Nov 18, 2023, 17:34 | Blog
Ana Sofia Carvalho Pais Silva: Our team from the AMC has participated in the All.Can International Strategic Workshop
Ana Sofia Carvalho Pais Silva, Researcher Phd Candidate at the Amsterdam UMC, recently shared on…
Nov 18, 2023, 17:27 | Blog
Marwan Fakih: We were the first to define the resistance of liver metastatic disease to IO in MSS CRC and to make a case for developing CPI combinations in non-liver metastatic disease
Nov 18, 2023, 17:20 | Insight
Natalia Baran: Our review paper on crosstalk between macrophages and cancer cells
Natalia Baran, Research Assistant Professor at MD Anderson Cancer Center, shared on LinkedIn: "Hot off…
Nov 18, 2023, 17:16 | Blog
Leon 'Jun' T.: A few interesting observations from the top 25 antibody drug conjugates bone marrow deals
Leon 'Jun' T., Scientific Advisor at Mianus Capital, shared on LinkedIn: "Updated on 2023-11-10 by…
Nov 18, 2023, 17:12 | Insight
Mark Lewis: Why I (almost) never bolus 5-Fluorouracil
Mark Lewis shared on Twitter/X: "WHY I (ALMOST) NEVER BOLUS 5-FLUOROURACIL I've been pondering this…
All: 709 Posts: 281 - 290